HOME >> BIOLOGY >> NEWS
New drugs for cancer therapy at international conference in Amsterdam

Among the drugs that will be discussed in Amsterdam over the next three days are bevacizumab, cetuximab, dasatinib, erlotinib, lapatinib, nilotinib, oblimersen sodium, sorafenib, and sunitinib. All of these have been approved or are awaiting regulatory approval in various cancer indications. In addition, a range of agents in earlier phases of development will be discussed. The TAT 2007 program incorporates presentations of results from early-phase clinical trials (phase I and phase II) that have not been released before.

Targeted anticancer agents are the subject of extensive research and development activities worldwide, often conducted in joint projects of academic research institutes and pharmaceutical companies. These drugs are characterized by the fact that they have a well-defined molecular target, which is known to play a role in the growth of tumors or the blood vessels supplying the tumor with nutrients.

Many leading cancer institutes from all over the world are represented at the TAT 2007 conference in Amsterdam. In total, about 600 delegates from over 40 countries will gather at the VU University Main Building in a conference organized by the Amsterdam-based NDDO Research Foundation in a partnership with the European Society for Medical Oncology (ESMO). Professor Giuseppe Giaccone, VU medical center, Amsterdam, is the President of this Conference.


'"/>

Contact: Marinus W. Lobbezoo
congress@nddo.org
31-348-442-251
European Society for Medical Oncology
8-Mar-2007


Page: 1

Related biology news :

1. MIT model could predict cells response to drugs
2. New target for HIV/AIDS drugs and vaccine discovered
3. Modified mushrooms may yield human drugs
4. UGR researchers design an alternative to blood test to detect drugs in the body
5. Could fungal collection hold the key to new life-saving drugs?
6. Sensitivity to diverse range of chemotherapeutic drugs linked to common pathway
7. Scientists develop new drugs to fight colon and breast cancer more effectively
8. Anti-inflammatory drugs interact with HRT, and more
9. Generic biologic drugs unlikely to offer significant savings
10. Stem cells provide new tool for studying disease and identifying ALS drugs
11. Enhancing chemotherapys efficacy: New agent has synergistic effect with standard drugs

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/20/2019)... SAN DIEGO (PRWEB) , ... January 16, 2019 , ... ... building and cooking events company. Not only has the company already hosted several ... to host Fortune 500 companies, Amazon and Janssen Pharmaceuticals, later this month. , ...
(Date:1/10/2019)... ... ... Dr. Beanlands is the Vered Chair and Division Head of Cardiology at the ... of its National Cardiac PET Centre, and Professor in the University's Division of Cardiology ... of Cellular and Molecular medicine. , He is a founding member of ASNC, member ...
(Date:1/8/2019)... and RALEIGH, N.C. (PRWEB) , ... January 07, ... ... micro acoustic and micro mechanical technologies and solutions for hearing instruments and specialty ... today announced BiometRIC, the first ever hearing aid receiver in canal with an ...
Breaking Biology News(10 mins):
(Date:1/8/2019)... ... ... The American Society of Gene and Cell Therapy’s (ASGCT) first ... up of industry leaders identified by the ASGCT board of directors. In total, the ... support ASGCT members designing transformative pilot studies in gene and cell therapy as they ...
(Date:1/4/2019)... ... January 01, 2019 , ... uBiome, the ... World Economic Forum Annual Meeting January 22-25, 2019 held in Davos-Klosters, Switzerland following ... World Economic Forum Annual Meeting brings together leaders of global society–the heads and ...
(Date:12/20/2018)... ... December 20, 2018 , ... New Year’s brings reflection ... changes in regulations in the European Union (EU) on the horizon, Jim Kasic, president ... , “The transition to the EU Medical Device Regulation (MDR), digital health, and big ...
(Date:12/18/2018)... ... 17, 2018 , ... ABCT , the Accelerator for ... to participate in the annual program. Twelve ventures will participate in the 6.5-month-long ... network. All startups receive an entrepreneur coach, access to active business professionals and ...
Breaking Biology Technology:
Cached News: